COMPANY > HISTORY        

  Oct.1960.
Founded Bukwang Co., Ltd.
  Mar.1962. Changed the firm name to
'Bukwang Pharmaceutical Ind. Co., Ltd.'
Oct.1978.
The 14th Chung-ang advertising grand prize award
   
  Oct.1980.
Founded the 1st Factory on the 14th
Chung-ang advertising grand prize award
Dec.1982.

The 2nd Korea broadcast advertising grand prize award
Apr.1985.
The 1st authorization K.G.M.P in Korea
Jun.1987. Founded synthesis factory
Aug.1988. Listed stocks on the stock market
Dec.1988.
Founded the 2nd factory
     
  Dec.1993.
Founded Bukwang R&D center, the 29th
Chung-ang advertising grand prize award
Nov.1995.
The 31st Chung-ang advertising grand prize award
Jan.1997.
Won a Prize for excellent cooperation
between capital and labor
Feb.1998.
License agreement with Triangle, Inc.,
Apr.1998.
Made a development right contract of new
hematopoietic stem cell promoting factor with ChoongAng Hospital and Ewha Woman's University
Jun.1998.
Licence agreement with Cheonam University for the
co-development of DNA and protein diagnostic reagent
     
  Mar.2000.
Invested in Anterogen, Inc.,
  May.2001.
Changed the firm name to 'Bukwang Pharmaceutical Co., Ltd.'
  Sep.2004.
Patent achievement: "Process for the preparation of
of 2'-fluoro-5-methyl-beta-L-rabinofuranosyluridine"
  Nov.2004.
License agreement with Eisia for the development of clevudine in 10 countries in Asia
  Jun.2005.
License agreement with Pharmasset for the development of clevudine
  Aug.2005.
Moved R&D center to Guro Digital Complex